Pravastatin Sodium Patent Expiration
Pravastatin Sodium is used for secondary prevention of coronary events in patients with a history of myocardial infarction and normal cholesterol levels. It was first introduced by Bristol Myers Squibb
Pravastatin Sodium Patents
Given below is the list of patents protecting Pravastatin Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pravachol |
US5622985 (Pediatric) | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
Oct 22, 2014
(Expired) | Bristol Myers Squibb |
| Pravachol | US5622985 | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
Apr 22, 2014
(Expired) | Bristol Myers Squibb |
Pravastatin Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List